A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

January 16, 2027

Study Completion Date

January 27, 2027

Conditions
Solid Tumor, Adult
Interventions
DRUG

CRB-701

Nectin-4 targeted Antibody Drug Conjugate (ADC)

DRUG

Anti-PD-1

checkpoint inhibitor

Trial Locations (44)

20141

RECRUITING

European Institute of Oncology IRCCS, Milan

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

22328

RECRUITING

Aresnsia Research Clinic Bucharest, Bucharest

28040

RECRUITING

Fundacion Jimenez Diaz (START), Madrid

28078

RECRUITING

Carolina BioOncology Institute, Huntersville

32806

RECRUITING

Florida Cancer Specialists, Orlando

34298

RECRUITING

ICM-Val d'Aurelle, Montpellier

34720

NOT_YET_RECRUITING

Istanbul Medeniyet University, Istanbul

35294

RECRUITING

O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham, Birmingham

37134

NOT_YET_RECRUITING

Centro Richerche Cliniche di Verona, Verona

44085

NOT_YET_RECRUITING

Institut de Cancerologie de l'Ouest, Saint-Herblain

46010

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

50314

RECRUITING

Careggi University Hospital, Florence

60521

RECRUITING

Hope and Healing Cancer Center, Hinsdale

60637

RECRUITING

University of Chicago, Chicago

68506

RECRUITING

Nebraska Hematology Oncology, Lincoln

75702

RECRUITING

Texas Oncology, Tyler

80218

RECRUITING

Rocky Mountain Cancer Centres, Denver

83114

NOT_YET_RECRUITING

Adana Numune Egitim ve Arastirma Hastanesi (Adana City Education and Research Hospital), Adana

86000

RECRUITING

CHU de Poitiers, Poitiers

91010

RECRUITING

City of Hope Cancer Center, Duarte

92037

RECRUITING

Moores Cancer Centre at UC San Diego Health, San Diego

94115

RECRUITING

Helen Diller Family Comprehensive Cancer Center - UCSF, San Francisco

94805

NOT_YET_RECRUITING

Gustave Roussy, Villejuif

98195

RECRUITING

Fred Hutchinson Cancer Center at University of Washington, Seattle

200347

RECRUITING

Centrul de Oncologie Sf. Nectarie, Iași

400015

RECRUITING

Aresnsia Research Clinic Cluj-Napoca, Cluj-Napoca

700106

RECRUITING

Centrul de Oncologie Euroclinic, Iași

06510

RECRUITING

Yale Cancer Center, New Haven

02215

RECRUITING

Dana-Faber Cancer Institute, Boston

00168

RECRUITING

Fondazione Policlinico Gemelli, IRCCS, Rome

08023

RECRUITING

Barcelona IOB Hospital Quironsalud (NEXT), Barcelona

08035

RECRUITING

Vall d-Hebron Institut d'Oncologia, Barcelona

06620

NOT_YET_RECRUITING

Ankara University, Ankara

Unknown

NOT_YET_RECRUITING

Ankara Etlik City Hospital, Ankara

B15 2TH

RECRUITING

University of Birmingham NHS Foundation Trust, Birmingham

CB2 0QQ

RECRUITING

University of Cambridge NHS Foundation Trust, Cambridge

CF15 7QZ

RECRUITING

Velindre Cancer Centre, Cardiff

LS9 7LP

RECRUITING

Leeds University Hospitals NHS Trust, Leeds

SE1 9RT

RECRUITING

Guy's and St Thomas' Clinical Research Facility, London

W12 0NN

RECRUITING

Imperial Experimental Cancer Medicine Centre, London

M20 4BX

RECRUITING

The Christie Hospital, Manchester

CH63 4JY

NOT_YET_RECRUITING

University of Liverpool - Clatterbridge Medical Centre, Metropolitan Borough of Wirral

SO16 6YD

NOT_YET_RECRUITING

University of Southampton, Southampton

Sponsors
All Listed Sponsors
collaborator

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

INDUSTRY

lead

Corbus Pharmaceuticals Inc.

INDUSTRY